Companies: 10,795·Total market cap: $144.5T
Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

PSTXNASDAQHealthcare
$9.50
+$0.00(+0.00%)
Market Cap$925933688
P/E Ratio—
52W High$9.67
52W Low$1.87
Overview

Poseida Therapeutics, Inc. (PSTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · PSTX · as of Mar 7, 2024

Latest filing snapshot

330
+16+5.10%vs prior year

Poseida Therapeutics, Inc. (PSTX) employee data is sourced from the annual SEC 10-K filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2023-12-31·Full-time · Global
Total Employees
330
Change (1Y)
+16
Growth % (1Y)
+5.10%
Revenue / Employee
$196.1K
Net Income / Employee
$-374.0K
Market Cap
$926M

PSTX Employee Count

2020 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2024-03-07330+16+5.10%
2023-03-09314+51+19.39%
2022-03-10263+57+27.67%
2021-03-11206——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Avid Bioservices, Inc.
CDMO
Avid Bioservices, Inc.
371#2
Poseida Therapeutics, Inc.
PSTX
Poseida Therapeutics, Inc.YOU
330#3
Gracell Biotechnologies Inc.
GRCL
Gracell Biotechnologies Inc.
314#4
Albireo Pharma, Inc.
ALBO
Albireo Pharma, Inc.
130#5
Chimerix, Inc.
CMRX
Chimerix, Inc.
79#6
Harpoon Therapeutics, Inc.
HARP
Harpoon Therapeutics, Inc.
45#7
Crescent Biopharma, Inc.
CBIO
Crescent Biopharma, Inc.
41
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · PSTX peer comparison

About PSTX employees

PSTX Employees · Headcount

Poseida Therapeutics, Inc. (PSTX) employee data is sourced from the annual SEC 10-K filing. As of 2023, Poseida Therapeutics, Inc. had 330 full-time employees globally. Full-time employees only. Global consolidated headcount.

Poseida Therapeutics, Inc. employs 330 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $196,070, reflecting the company's operational efficiency.

Poseida Therapeutics, Inc.'s workforce increased by 16 (5.10%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Poseida Therapeutics, Inc.'s revenue per employee of $196,070 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

PSTX Employees · 5 questions

As of the latest SEC 10-K filing (2023), Poseida Therapeutics, Inc. had 330 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Poseida Therapeutics, Inc. employee counthow many employees does Poseida Therapeutics, Inc. havePSTX total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-03-07